Avacta, LSTM collaborate to clinically validate Covid-19 antigen rapid saliva test
Avacta is working with Cytiva for the development of the rapid and saliva-based coronavirus antigen test
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Aug 20
Avacta is working with Cytiva for the development of the rapid and saliva-based coronavirus antigen test
10 Aug 20
The Guardant360 CDx has been designed to deliver important genomic information to oncologists from a simple blood draw
10 Aug 20
AnPac Bio performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological,…
10 Aug 20
Co-Diagnostics is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology
07 Aug 20
The FDA previously granted a De Novo designation for the assay to detect MRD in patients with multiple…
07 Aug 20
Curated menu of Off-the-Shelf RNAscope probes provide seamless molecularly-guided region of interest selection for use with the new…
06 Aug 20
The high-throughput molecular diagnostic testing system has the capacity to analyse up to 6,000 samples in a single…
06 Aug 20
The probe-based reverse transcription PCR test will allow to identify SARS-CoV-2 by targeting conserved regions of the viral…
06 Aug 20
The company's Sight OLO analyser is designed to automate the identification and quantification of various blood cell types…
06 Aug 20
Along with sentinel assays, pooled testing will be another integral tool in Eurofins’ comprehensive SARS-CoV-2 SAFER WORKTM programme